(Q50920537)

25 March 2018

title

Hodgkin's disease in patients older than 70 years of age: a registry-based analysis. (English)

1 reference

25 March 2018

author name string

Forsyth PD

1

1 reference

25 March 2018

Bessell EM

2

1 reference

25 March 2018

Moloney AJ

3

1 reference

25 March 2018

Leach IH

4

1 reference

25 March 2018

Davies JM

5

1 reference

25 March 2018

Fletcher J

6

1 reference

25 March 2018

publication date

1 September 1997

1 reference

25 March 2018

European Journal of Cancer

published in

1 reference

25 March 2018

volume

33

1 reference

25 March 2018

issue

10

1 reference

25 March 2018

page(s)

1638-1642

1 reference

25 March 2018

Management of malignant lymphoma in the elderly. An EORTC retrospective evaluation

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900119-6

7 January 2021

Hodgkin's disease in the elderly. A series of 30 patients aged older than 70 years

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900119-6

7 January 2021

Hodgkin's disease in the elderly: a retrospective clinicopathologic study of 61 patients aged over 60 years

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900119-6

7 January 2021

Survival in Hodgkin's disease by stage and age

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900119-6

7 January 2021

Lymphocyte function in untreated Hodgkin's disease: an important predictor of prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900119-6

7 January 2021

Hodgkin disease in the elderly. A registry-based analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900119-6

7 January 2021

Treatment outcome in Hodgkin's disease in patients above the age of 60: A population-based study

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900119-6

7 January 2021

Twenty years of MOPP therapy for Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900119-6

7 January 2021

ChlVPP combination chemotherapy for Hodgkin's disease: long-term results

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900119-6

7 January 2021

Non-Hodgkin's lymphoma in elderly patients: a phase II study of MCOP chemotherapy in patients aged 70 years or over with intermediate- or high-grade histology

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900119-6

7 January 2021

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900119-6

1 reference

7 January 2021

Prognostic factors in Hodgkin's disease with special reference to age

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900119-6

7 January 2021

Hodgkin's disease in patients over sixty years old

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900119-6

7 January 2021

Factors affecting relapse following chemotherapy for Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900119-6

7 January 2021

10.1016/S0959-8049(97)00119-6

Identifiers

DOI

1 reference

25 March 2018

PubMed ID

9389927

1 reference

25 March 2018